We offer a variety of hair options for women and men ranging from basic cut and style to highlights, gloss, treatments and more.

Learn More


From pedicure and manicures to acrylic nails and toes we have just the right option to help you look your best.

Learn More


Everyone deserves to be pampered. We can  help you relax and rejuvenate w/ a facial, massage or with one of our spa packages.

Learn More


Beta blockers usually do not reduce threat of colorectal cancer A fresh study has discovered that.

Even though the investigators broke down their analyses by period useful of beta blockers, particular types of beta blockers, substances , and sites within the colon or rectum where colorectal malignancy developed, there is no link. General, the results of the study usually do not support the hypothesis that using beta blockers can lower one’s colorectal malignancy risk. The results also indicate the need for considering patient features and other elements that may influence the outcomes of studies that appear at how medicines affect patients’ tumor risk.. Beta blockers usually do not reduce threat of colorectal cancer A fresh study has discovered that, unlike current thinking, taking beta blockers that treat high blood circulation pressure does not reduce a person’s threat of developing colorectal cancer. Continue reading

Chief scientific officer at The Tumor Institute of New Jersey.

CINJ scientist receives University of Texas award for cancers therapeutic research In recognition of efforts manufactured in cancer therapeutic research, Joseph R viagra-vs-cialis.htm . Bertino, MD, chief scientific officer at The Tumor Institute of New Jersey , offers been honored with The Jeffrey A. Gottlieb Memorial Award sponsored by The University of Texas MD Anderson Tumor Middle. CINJ is a Center of Excellence of UMDNJ-Robert Solid wood Johnson Medical School. Related StoriesMeat-rich diet may increase kidney tumor riskViralytics enters into medical trial collaboration contract with MSDSausages With Antioxidants From Berries To Prevent CancerThe Jeffrey A. Continue reading

With results from a schizophrenia study using Cogstate&39.

The results figured Lurasidone improved the cognition working of the individuals at the six week, three month and six month milestones. Maruff. This four-season trial, a multi-site international effort, will check three anti-amyloid-beta interventions: gantenerumab, solanezumab and a third, as yet undetermined, medication.?.. Cogstate test shows effective treatment choice for schizophrenia Medical technology company Cogstate continues to strengthen its position as an essential partner for measuring cognition in important studies all over the world, with results from a schizophrenia study using Cogstate's check published in a significant scientific journal. Continue reading

Head in mRNA -based drug advancement.

In neuro-scientific cancer immunotherapy CureVac has already been collaborating with the Ludwig Cancer tumor Analysis Institute to enable medical testing of novel cancers immunotherapy treatment plans. In neuro-scientific prophylactic vaccines CureVac is usually and the like collaborating with Sanofi Pasteur, In-Cell-Art, Janssen and DARPA Pharmaceuticals. About Boehringer Ingelheim The Boehringer Ingelheim group is among the world’s 20 leading pharmaceutical businesses. Headquartered in Ingelheim, Germany, Boehringer Ingelheim operates with 142 affiliates and a complete greater than 47 globally,400 employees. Continue reading

CPRIT awards $36.

CPRIT was established in 2007 after Texas voters authorized a constitutional amendment that authorized the state to fund cancer research and prevention programs. These awards, made after a rigorous peer-review process, resulted in UT Southwestern getting the most funding of any individual Texas organization in CPRIT’s latest circular of grants. Awards to UT Southwestern researchers were part of $116 million allocated for 22 tasks at 16 Texas-based educational institutions and private companies. This circular of grants is part of $216 million expected to end up being awarded by the institute this year. Financing for UT Southwestern announced March 24 included more than $30 million to support tasks involving 20 pre-eminent researchers. Continue reading

The many vital issue is to obtain treated at the initial opportunity after diagnosed.

This may murder the tumor when gotten not long after it begins regularly. The inconvenience is usually that it not only executes malignancy. It slaughters great cells aswell. Chemotherapy is toxic chemical. It has been known to murder individuals. It not only makes hair turn out, you are made by it debilitated. Some individuals decline to proceed with it. On the off possibility that you have been diagnosed with disease, this is actually the way to manage yourself. Realize whatever you can about malignancy and its own medicines and settle on your own choice. Chemotherapy and Radiation aren’t by any means the only intends to treat growth. Continue reading

Closing in on neurologic biomarker diagnosis By Eleanor McDermid.

In every, the team assessed 453 CSF samples from sufferers with dementia or parkinsonian disorders and 107 from healthy volunteers. The 5th biomarker – neurofilament light chain – distinguished 90 PD individuals from 105 with atypical parkinsonism with an precision of 93 percent. This was markedly increased in individuals with atypical parkinsonism disorders. The other biomarkers did not add to the diagnostic precision of neurofilament light chain. Perrin notes that the fact that the four Advertisement biomarkers were ‘multiplexed’ into a solitary high-throughput assay for this research makes this panel particularly interesting. But he cautions: It remains to be observed whether this panel might have utility to classify vascular dementia or the frontotemporal dementias, that have been not one of them scholarly study; additional markers may be required for that purpose. Continue reading

CellCentric out-licenses development.

Many illnesses including malignancy involve a loss of cell fate control. Oftentimes this is connected with aberrant epigenetic changes to chromatin: dynamic adjustments of DNA and its linked proteins, including histones. These epigenetic alterations are caused by a range of enzymes. Initial therapeutic curiosity has been centered on inhibiting HDAC and DNMTs. It is becoming increasingly clear that there are many other crucial epigenetic related enzymes which can be targeted and which might offer greater specificity of action. Continue reading

Asthma Treatment and Diagnosis If you visit the emergency division for an asthma attack.

Report any relative unwanted effects you are having together with your medications.These will be the goals of treatment: prevent ongoing and bothersome symptoms;prevent asthma attacks;prevent attacks serious enough to need a stop by at your provider or a crisis hospitalization or department;carry on with regular activities;maintain near-regular or regular lung function; andhave as few unwanted effects of medication as you possibly can.. Asthma Treatment and Diagnosis If you visit the emergency division for an asthma attack, medical care provider will initial assess how severe the attack is. Continue reading

Caring for chronic diseases in a fragmented health care system Ed Wagner.

Caring for chronic diseases in a fragmented health care system Ed Wagner, MD, MPH, knew there had to be a better way. He and Group Health colleagues lay out 15 years back to explore how better to engage patients with chronic diseases in effective care and attention. With Robert Hardwood Johnson Foundation support, the Chronic was developed by them Care Model. More than 1,500 U.S. And international medical practices have adopted the Model. Now the biggest roundup of proof on how the Model performs in practice confirms that it works. This review is normally in the January/February 2009 problem of Health Affairs, centered on an integral part of reforming health care: caring for chronic illnesses in a fragmented healthcare system. Continue reading

Celsion acquires all property of EGEN Celsion Corporation.

Sidley Austin LLP and O'Melveny & Myers LLP acted as legal counsel to Celsion because of this transaction.. Celsion acquires all property of EGEN Celsion Corporation , an oncology drug development organization, today announced the completion of the acquisition by Celsion of all of the possessions of EGEN substantially, Inc. , a privately-held biopharmaceutical company centered on the development of nucleic acid-centered therapeutics for the treatment of cancer and other hard to treat diseases. Continue reading

CSCRM and CWRU receive $1M to progress MultiStem therapy for SCI Athersys.

Athersys and a united group of CWRU experts led by Dr. Jerry Silver, a respected neuroscientist, possess demonstrated that MultiStem decreases the inflammation occurring following spinal cord damage and supports neuronal development. Silver and associates of his research group at latest scientific conferences like the International Culture for Stem Cell Analysis 8th Annual Meeting demonstrated that in preclinical types of SCI MultiStem suppressed the neuroinflammation which outcomes in additional axonal harm following such neurological damage. Silver’s function also provides proof that MultiStem inhibits axonal ‘dieback’ normally observed pursuing SCI and promotes the re-development of the axons following damage. Continue reading

Including immunology.

An experienced supplier will ensure that everything you have ordered reaches you safely within the stipulated time. These are the huge benefits you will be able to avail if you buy laboratory equipment from a provider that has been providing quality items like plastic cell tradition flasks, tubes, gloves, etc., from leading manufacturers for an extended period of time.. Buy Laboratory Apparatus From A Reputable Supplier Research and medical laboratories are more often than not engaged in performing regular and advanced methods, including immunology, microbiology, hematology, etc. It is important that laboratories have the necessary equipment to carry out these procedures that they must be for getting the required results. Continue reading

After comprehensive review by Ambrys personnel of geneticists and medical directors.

.. Ambry to supply CLIA-approved exome providers for applications in clinical diagnostics Ambry Genetics today announces that it is the first laboratory to provide CLIA-approved exome providers for applications in clinical diagnostics. After comprehensive review by Ambry’s personnel of geneticists and medical directors, these results shall allow clinicians to diagnose affected patients with conditions that have eluded traditional diagnostic approaches. Continue reading

Vice President and Mind of U.

Food and Medication Administration seeking authorization for the oral multi-kinase inhibitor regorafenib for the treating individuals with metastatic colorectal tumor . Cyrus, M.D., Vice President and Mind of U.S. Medical Affairs, Bayer Health care Pharmaceuticals. That is a significant step toward our objective of bringing brand-new treatment plans to people coping with cancer. The submission is founded on the outcomes of a pivotal, global Stage III CORRECT trial. Outcomes from the analysis were first provided at the Annual Gastrointestinal Cancers Symposium of the American Culture of Clinical Oncology in January 2012 and you will be presented at the forthcoming ASCO annual conference in Chicago, IL in early June 2012. Continue reading